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ABSTRACT The yeast U4yU6zU5 pre-mRNA splicing small
nuclear ribonucleoprotein (snRNP) is a 25S small nuclear
ribonucleoprotein particle similar in size, composition, and
morphology to its counterpart in human cells. The yeast U4y
U6zU5 snRNP complex has been purified to near homogeneity by
affinity chromatography and preparative glycerol gradient sed-
imentation. We show that there are at least 24 proteins stably
associated with this particle and performed mass spectrometry
microsequencing to determine their identities. In addition to the
seven canonical core Sm proteins, there are a set of U6 snRNP
specific Sm proteins, eight previously described U4yU6zU5
snRNP proteins, and four novel proteins. Two of the novel
proteins have likely RNA binding properties, one has been
implicated in the cell cycle, and one has no identifiable sequence
homologues or functional motifs. The purification of the low
abundance U4yU6zU5 snRNP from yeast and the powerful
sequencing methodologies using small amounts of protein make
possible the rapid identification of novel and previously uniden-
tified components of large, low-abundance macromolecular ma-
chines from any genetically manipulable organism.
Eukaryotic pre-mRNA must undergo extensive processing in the
nucleus before it is converted into the mature mRNA species
competent for translation into protein. One important processing
step is the excision of intervening sequences, termed introns,
which are present within the coding sequences. Removal of
introns is effected by the pre-mRNA splicing machinery, which is
composed of five phylogenetically conserved small nuclear RNAs
(snRNAs) assembled into small ribonucleoprotein particles
(snRNPs) and several non-snRNP associated proteins (1). Once
assembled onto pre-mRNA, the massive RNP termed the spli-
ceosome removes the intronic RNA sequences by two ordered
transesterification reactions ligating the two exons together,
forming the mature message. The biochemistry of the mamma-
lian spliceosomal snRNPs has been extensively studied, and many
of the protein components have been purified and their genes
cloned (2–4). The budding yeast Saccharomyces cerevisiae has
been very useful in the study of pre-mRNA splicing, as it is
amenable to genetic manipulations. The low abundance of pre-
mRNA splicing snRNPs, however, has made their isolation
technically challenging. Several yeast proteins involved in splicing
have been identified by conditional growth mutations that pro-
duce a pre-mRNA splicing defect (5–7) from synthetic lethal
analysis (8, 9), identification of second-site suppressors (10–13),
two-hybrid analysis (14), and, most recently, from the direct
biochemical purification of the yeast U1 snRNP (15, 16).
In yeast, there are an estimated 100–200 copies of each
spliceosomal snRNA (17) as compared with 100,000–1,000,000
snRNA copies in mammalian cells (18). This discrepancy in
abundance has made the purification of yeast snRNPs much more
difficult, especially in the case of the yeast U4yU6zU5 tri-snRNP,
which exists in equilibrium with the individual U4yU6 and U5
snRNPs and is therefore less abundant than the respective
individual snRNPs (19). The U4yU6zU5 tri-snRNP undergoes
dynamic rearrangements that assemble the particle from individ-
ual U4, U5, and U6 snRNPs. U4 and U6 snRNPs associate into
a U4yU6 snRNP particle by extensive base pairing mediated by
the putative RNA annealing factor Prp24 (21). The U4yU6
snRNP then associates with the U5 snRNP to form the U4y
U6zU5 snRNP, which sediments at 25S in glycerol gradients (20).
The U4yU6zU5 snRNP joins the splicing reaction after the
formation of the pre-spliceosome, which is composed of the
pre-mRNA and the U1 and U2 snRNPs. U6 then replaces U1 at
the 59 splice site in an ATP-dependent, Prp28-mediated exchange
(22). The U4 snRNP then is released from the spliceosome, likely
in a Brr2 RNA helicase-mediated reaction (23), and the U2, U5,
and U6 snRNPs remain associated with the spliceosome. The U5
snRNP is responsible for the alignment of the two exons to be
spliced together (24). The U6 and U2 snRNAs undergo dynamic
rearrangements to assemble into the presumed catalytic core of
the splicing reaction (1). After splicing occurs and the spliceo-
some dissociates, the U4yU6zU5 snRNP recycles, and the process
is repeated with a new pre-mRNA. The identity of all of the
proteins bound to these rapidly changing particles and which ones
may leave and join remain to be determined.
The U1, U2, U4, and U5 snRNPs each contain the canonical
Sm proteins B (and B9 in mammals), D1, D2, D3, E, F, and G (25).
In yeast, it has not been previously demonstrated that the SmB
protein associates with these snRNPs, and, although it was not
isolated with purified U1 snRNP, U1 snRNA can be immuno-
precipitated by using epitope-tagged SmB (16). U6 snRNA is
associated with the Sm-like proteins termed Lsm2-Lsm8 (ref. 26;
J. Beggs personal communication) as well as the Prp24 protein
(27). Although many U4yU6zU5 snRNP proteins have been
identified (10, 23, 28–36), the methods used in their discovery
have not ruled out the possibility that other proteins may be
associated with these snRNPs.
We have purified the yeast U4yU6zU5 snRNP by affinity
chromatography of a doubly epitope-tagged SmD3 protein (37),
a component of the spliceosomal snRNPs. By using two affinity
chromatography steps followed by preparative glycerol gradient
sedimentation, the triple snRNP was purified to near homoge-
neity, and the polypeptides were isolated and identified by mass
spectrometry. We show that there are at least 24 proteins stably
associated with the U4yU6zU5 snRNP, 4 of them novel. This is
similar to the '20–25 proteins isolated in purified human U4y
U6zU5 snRNP (38). Previous studies have shown that the ultra-
structure of the yeast U4yU6zU5 snRNP was very similar to that
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of the human U4yU6zU5 snRNP (20), indicating that a similar
protein complement is likely. Tandem mass spectrometry is
proving to be a powerful and concise means of identifying the
components of low abundance macromolecular complexes from
organisms whose genomes have been sequenced.
MATERIALS AND METHODS
Yeast Strains, Plasmids, and Molecular Biology. Yeast strain
JWY2445 (37) MATa his1 leu2–1 trp1-D101 ura3–52
smd3D1::LEU2 1 YCp50-SMD3 was kindly provided by John
Woolford (Carnegie Mellon University). Plasmid pSmD3–28
contains an octahistidine epitope followed by two tandem repeats
of the polyoma Py epitope (39) at the extreme C terminus of the
SmD3 polypeptide introduced by a two step PCR cloning pro-
cedure. Plasmid pSmD3–28 was introduced by lithium acetate
transformation (41) of strain JWY2445, and transformants were
selected by using synthetic yeast medium plates lacking trypto-
phan. Plasmid shuffle to remove the wild-type YCp50-SmD3
plasmid was performed on synthetic yeast medium lacking tryp-
tophan and containing 5-fluoroorotic acid to create strain
YSS201. Bacterial manipulations were according to standard
procedures (42). All enzymes were purchased from New England
Biolabs or prepared in this laboratory, chemicals were purchased
from Sigma, and media ingredients were from Difco.
Yeast Growth and Extract Preparation. Strain YSS201 was
grown in a 200-liter fermentor in yeast extractypeptoneydextrose
medium at 30°C to OD at '3.0 and was harvested in a continuous
flow centrifuge. The cell paste was suspended 1:1 (wtyvol) in
buffer A (10 mM Hepes, pH 7.9y10 mM KCl) and was extruded
into liquid nitrogen. Extracts were prepared by liquid nitrogen
homogenization in a Waring blender essentially as described (43)
and were dialyzed into the buffer used to perform the chroma-
tography.
Affinity Chromatography and Glycerol Gradient Sedimenta-
tion. Antibody affinity matrix was prepared by using supernatant
from hybridoma cell line AK6967 grown in serum free medium
II (GIBCOyBRL). Cell supernatant was incubated for 2 hr with
Protein-G Sepharose (Amersham Pharmacia) and was
crosslinked with dimethylpimelimidate as described by the man-
ufacturer. Antibody was conjugated to the matrix at a concen-
tration of 1 mgyml bed volume of resin. Extract dialyzed against
buffer D50 or D250 [buffer D (20 mM Hepes, pH 7.9y8%
glyceroly10 mM b-mercaptoethanoly0.5 mM phenylmethylsulfo-
nylfluoridey1 mg/ml leupeptiny1 mg/ml pepstatin) containing 50
or 250 mM KCl] was passed over the affinity resin at a flow rate
of 5 mlyhr, was washed with 15 column volumes of buffer D50 or
D250, and was eluted with 5 column volumes of buffer D50 or
D250 containing 100 mgyml HPLC-purified peptide EYMPME
(synthesized at the Caltech Polymer Synthesis Facility, Pasadena,
CA) to compete for antibody binding. Ni–nitrilotriacetic acid
(NTA) (Qiagen) chromatography was performed on the antibody
affinity chromatography eluate. After loading, the column was
washed with 15 column volumes of buffer D containing 15 mM
imidazole. Elution of snRNPs from the Ni-NTA matrix was
effected by incubation with buffer D containing 100 mM imida-
zole. Linear glycerol gradients (10–30% gradients) were pre-
pared at various KCl concentrations in 20 mM Hepes (pH 7.9),
1.5 mM MgCl2, 0.01% Nonidet P-40, 10 mM b-mercaptoethanol,
1 mgyml leupeptin, and 1 mgyml pepstatin and were sedimented
at 29,000 rpm for 24 hr at 4°C in a Beckman SW41 rotor. RNA
and protein were isolated as described (20) and were stored at
280°C.
RNA Analysis, Protein Analysis, and Mass Spectrometry.
RNA was analyzed on 5% polyacrylamide (19:1), 8.3 M urea, and
13 TBE (90 mM Trisy64.6 mM boric acidy2.5 mM EDTA, pH
8.3) gels and was stained with silver (44). RNA markers were
purchased from Ambion. Proteins were separated on 12% SDSy
PAGE gels prepared as described (45). Protein markers were
purchased from NOVEX (San Diego). Proteins were stained
with Coomassie blue R-250 (GIBCOyBRL) and were excised
from the SDSyPAGE gels. Protease digestion and sample prep-
aration for nano-electrospray MSyMS mass spectrometry were
performed as described (46, 47).
RESULTS
Purification of Total Yeast Spliceosomal snRNPs. By placing
an epitope tag at the SmD3 C terminus that consists of an
octahistidine sequence followed by two repeats of an epitope
from a polyoma viral protein (39), we were able to purify all of
the spliceosomal snRNPs in two steps. First, whole cell extract was
passed over an immunoaffinity column to enrich for the epitope
tag on the SmD3 protein. Elution was achieved by the incubation
of the resin with a molar excess of the epitope in peptide form.
A second affinity purification was performed to remove contam-
inating proteins that copurified on the antibody matrix: The
antibody column eluate was passed over a 0.3–0.5 ml Ni-NTA
column, was washed extensively, and was eluted by addition of 100
mM imidazole.
Single affinity chromatography by using either the antibody
resin or the Ni-NTA resin did not yield a snRNP fraction of
sufficient purity. Using Ni-NTA chromatography alone resulted
in the retention of ,5% of the snRNPs. Inclusion of two separate
blocks of eight consecutive histidine residues was not sufficient to
compete for the large number of polyhistidine containing pro-
teins present in yeast (data not shown). In the first lane of Fig. 1B,
the bulk proteins eluted from the antibody affinity column are
shown. The major band at '84 kDa is the His4 protein as
determined by mass spectrometry. This protein does not contain
sequences related to the antibody epitope but copurifies none-
theless. In Fig. 1B, lane 2, the bulk proteins from a subsequent
Ni-NTA chromatography step are shown. The His4 band as well
as other likely contaminating minor bands are no longer present;
however, many of the proteins remain.
FIG. 1. Total RNA and protein eluted from affinity chromatography
purification. (A) Total RNA from the Ni-NTA elution step. Ten micro-
grams of total snRNPs from the Ni-NTA eluate were phenol-extracted,
and RNA was precipitated with ethanol. Resuspended RNA was run on
a 5% polyacrylamide gel and was stained with silver. Positions of U1, U2,
U4, U5L, U5S, and U6 snRNAs are shown. (B) Total protein from each
step of the affinity purification. The organic phase of the phenol extrac-
tions from 10 mg of protein from the a-Py (lane 1) and Ni-NTA (lane 2)
chromatography steps was precipitated with acetone, and recovered
proteins were run on a 12% SDSyPAGE gel. Positions of the epitope-
tagged SmD3 protein and the contaminant His4 are indicated.
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The RNA species eluting from the Ni-NTA column are shown
in Fig. 1A. Note the absence of contaminating tRNA and rRNA
in this fraction. The identity of the snRNAs was confirmed by
primer extension of the bulk RNA with primers corresponding to
individual RNAs yielding products of a defined length (data not
shown). For reasons that are not well understood, '50–60% of
the U1 and U2 snRNPs are present in the antibody column flow
through whereas the U4yU6 and U5 snRNPs appear to be
quantitatively bound in this step (data not shown). It is possible
that either the epitopes on the SmD3 protein are not as readily
accessible in these snRNPs, or perhaps the snRNAs in the
flow-through are not fully assembled snRNPs.
Purification of the U4yU6zU5 snRNP. The low abundance of
the yeast U4yU6zU5 snRNP necessitated the pooling of five
purifications to obtain enough material to perform mass spec-
trometric sequencing of the proteins. A total of 750 ml of yeast
whole cell extract was passed over five 1-ml antibody affinity
columns (150 ml of splicing extract each) and was eluted with
buffer D50 containing 100 mgyml competitor peptide. The elu-
ates then were passed over five 0.5-ml Ni-NTA columns and were
eluted with buffer D50 containing 100 mM imidazole. A total of
350 mg of total spliceosomal snRNPs was layered onto 16 10–30%
glycerol gradients. Fractions 22–25 (measured from the top)
always contained the U4yU6zU5 snRNP with minor amounts of
U1 and U2 snRNP (Fig. 2A). Densitometric analysis of serial
dilutions of these fractions showed that the U4yU6zU5 snRNAs
were present in .100-fold molar excess over the U1 or U2
snRNPs.
Fractions 22–25 of the 16 gradients were phenol extracted, and
the organic phase was precipitated with acetone. The precipitated
proteins were resuspended in SDSyPAGE gel loading buffer and
were separated electrophoretically on a 12% high-TEMED gel
(45). In Fig. 2B, the proteins of the yeast U4yU6zU5 snRNP are
indicated. The 24 proteins identified in the yeast U4yU6zU5
snRNP are listed in Table 1. The minor contaminating band
migrating at 35-kDa between Prp4 and Snu23 is glyceraldehyde-
3-phosphate dehydrogenase isoforms 1, 2, and 3, the bulk of
which occurs at the top of the gradient (data not shown). This
protein represents 20% of the total soluble protein in yeast (48)
and also was found to be a contaminant in the U1 snRNP
purification protocol (15). Two possible explanations for the
copurification of this enzyme with the U1 and U4yU6zU5
snRNPs are (i) nonspecific interaction with the carbohydrate
based matrices involved in the affinity purification steps andyor
(ii) nonspecific interaction with the many phosphate moieties in
the U4, U5, and U6 snRNAs. The other minor contaminating
bands were not analyzed by mass spectrometry, but, by size, some
can be correlated to the known U1 snRNP proteins, which are
likely to be present as shown by RNA analysis of the fractions
used (Fig. 2A).
Mass Spectrometry Identification of Purified U4yU6zU5
snRNP Proteins. We analyzed all of the proteins extracted from
the SDSyPAGE gels slices by nano-electrospray tandem mass
spectrometry. After in-gel digestion with trypsin, the peptide
fragments were extracted from the gel matrix and were separated
by HPLC. The individual peptides were identified by mass and
were isolated and fragmented. An example is shown in Fig. 3. The
1,158-dalton tryptic peptide from Brr2 was isolated (Fig. 3A) and
fragmented by high energy collision with argon gas. The resulting
fragments were analyzed in a second mass spectrometer (Fig. 3B)
and the B and Y99 ions corresponding to the fragmented masses
from the N and C termini, respectively, were determined. The
protein sequence PDISSD was determined by inverting the
sequence shown in Fig. 3B because these ions correspond to single
amino acid truncations from the C terminus. The peptide se-
quence tags derived from all of the analyzed peptides were
compared against a theoretical trypsin digestion of all of the
proteins in the OWL database (Rockefeller Univ., New York). For
each of the U4yU6zU5 snRNP proteins, a single yeast ORF could
be identified. This procedure was repeated for all of the U4y
U6zU5 snRNP proteins.
All Canonical Sm Core Proteins of Spliceosomal snRNPs Are
Present in the Yeast U4yU6zU5 snRNP. Many of the lower
molecular weight proteins in the U4yU6zU5 snRNP (Fig. 2B)
correspond to the Sm core proteins present in spliceosomal
snRNPs. The D1, D2, D3, E, F, and G polypeptides are all present
in the U4yU6zU5 snRNP, as was shown to be the case in the U1
snRNP (15). Note that the SmD3 protein is shifted to a higher
relative molecular weight because of the presence of the affinity
tag. The SmB protein, which was not stoichiometrically repre-
sented in the purified U1 snRNP (16), is present in the U4yU6zU5
snRNP. It appears by Coomassie blue staining to be present in
twice the amount of closely migrating proteins, as SmB should be
stably associated with both the U4 and U5 snRNPs.
A Set of U6-Specific Sm Proteins Are Present in the Yeast
U4yU6zU5 snRNP. U6 snRNA does not contain a canonical Sm
binding site for the assembly of the Sm core onto the RNA (49).
It does, however, have a set of proteins similar to the canonical
Sm proteins (J. Beggs personal communication). The Lsm4yUss1
polypeptide has been shown to associate with the U6 snRNP (26)
and is present in the isolated U4yU6zU5 snRNP. The mass of the
protein in the band indicates that it is likely to be present in one
copy per U4yU6zU5 snRNP. Lsm2, Lsm5, Lsm6, and Lsm8 were
not visible by Coomassie staining of the gel but were fortuitously
identified as proteins comigrating with the canonical Sm protein
bands. Lsm3 and Lsm7 were not identified in this analysis because
FIG. 2. Glycerol gradient purification of the U4yU6zU5 snRNP.
(A) RNA extracted from fractions 22–27 from a 10–30% glycerol
gradient was run on a 5% polyacrylamide gel and was stained with
silver. Positions of the snRNAs are indicated. (B) Proteins associated
with the U4yU6zU5 snRNP. Proteins from 64 glycerol gradient
fractions were precipitated with acetone, were run on a 12% high
TEMED SDSyPAGE gel, and were stained with Coomassie blue.
Positions of the 24 stably associated U4yU6zU5 snRNP proteins are
indicated.
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we did not analyze the regions of the gel in which they migrated.
Indeed, tagged Lsm3 or Lsm7 extracts co-immunoprecipitate U4,
U5 and U6 snRNAs, indicating their presence in the U4yU6zU5
snRNP (J. Beggs, personal communication).
Proteins Previously Shown to Associate with U4yU6zU5
snRNP. The Prp8, Brr2, and Snu114 proteins are known to
associate with the U5 as well as the U4yU6zU5 snRNP. Prp8,
which is calculated to have a molecular mass of 280 kDa migrates
at '260 kDa, Brr2 (calculated molecular mass 5 246 kDa)
migrates aberrantly at '205 kDa, and Snu114 (calculated mo-
lecular mass 5 114 kDa) migrates normally. Five additional
proteins have been shown to be associated with the U4yU6zU5
snRNP. The Prp6, Prp31, Prp3, Prp4, and Prp38 proteins migrate
close to their predicted molecular mass (104, 56, 56, 52, and 28
kDa, respectively; refs. 28–30, 35, and 36). The ability of this
technique to identify Prp31 and Prp3 in a single band demon-
strates that, if other proteins were comigrating, they likely would
have been identified.
Novel Proteins Associated with the U4yU6zU5 snRNP. Four
novel proteins were isolated in the gradient purified U4yU6zU5
snRNP. In keeping with the nomenclature for other isolated
snRNP proteins, the novel U4yU6zU5 snRNP proteins have been
designated Snu (SNUrp associated) proteins with the corre-
sponding molecular weight. Snu66 is a novel 66-kDa protein that
migrates aberrantly at '80 kDa. There are sequence homologues
in humans and C. elegans with homology constrained to the N and
C termini. There are, however, no identifiable functional se-
quence motifs. Snu23 is a 23-kDa protein that migrates aberrantly
at 30 kDa. Snu23 contains a putative zinc finger motif, and there
exist in the database weakly homologous proteins from human
and fly containing regions of homology restricted to the zinc
finger motif, but nothing that clearly resembles a Snu23 homo-
logue. Dib1 is a 17 kDa protein that previously has been shown
from budding yeast and fission yeast (50) to be a likely cell cycle
component (see below). Its presence in stoichiometric amounts,
along with the fact that it copurifies through two chromatography
steps and sediments at 25S in a glycerol gradient, is good evidence
that it is a U4yU6zU5 snRNP component. The fourth novel
protein associated with the U4yU6zU5 snRNP is a 13-kDa
protein termed Snu13. There are homologues of this protein
present in several organisms (Fig. 4), all with a high degree of
homology. Snu13 is homologous to the Nhp2 protein, a basic
protein with homology to ribosomal proteins (51), indicating that
Snu13 may have RNA binding capacity. Indeed, Nhp2 is a
component of the H BOXyACA motif small nucleolar RNPs,
suggesting that Snu13 and Nhp2 may have a similar function in
their respective RNPs.
DISCUSSION
Purification of the Yeast U4yU6zU5 snRNP. We have purified
the yeast U4yU6zU5 snRNP to near homogeneity and have
identified 24 proteins that copurify through two affinity chroma-
tography steps and cosediment with the U4, U5, and U6 snRNAs
in glycerol gradients. Isolation of U4yU6zU5 snRNP at 50 mM
KCl or 250 mM KCl produced essentially identical results (data
not shown) with only minor variations in the abundance of some
proteins. The identification by mass spectrometry of the known
proteins Prp8, Brr2, Snu114, Prp6, Prp3, Prp31, Prp4, Prp38, and
the core Sm proteins indicates that this purified 25S complex is
indeed the yeast U4yU6zU5 snRNP. At least some of the faintly
staining protein bands present in these fractions are likely to be
U1 and U2 snRNP proteins (Fig. 2A). Because of the absence of
any mass spectrometric data indicating the proteins identified in
this study are known U1 or U2 snRNP proteins, it is likely that
the novel proteins we have identified are indeed associated with
the U4yU6zU5 snRNP.
Purified human U4yU6zU5 snRNP also contains '20–25
proteins. The human Prp8 homologue (52), the Brr2 homologue
(32), the Snu114 homologue (33), the Prp3 and Prp4 homologues
(4, 53), and the Sm core proteins (54) all have been shown to be
associated with the human U4yU6zU5 snRNP. It will be very
interesting to see whether the remaining uncharacterized human
U4yU6zU5 snRNP proteins correspond to any of the new pro-
teins identified in this study.
U6 Specific Sm Proteins. The Lsm proteins are Sm-like
proteins associated with U6 snRNA. Although we have not
identified a complete set of Lsm2-Lsm8, the two that were not
identified by mass spectrometry have been shown by others to
immunoprecipitate U4yU6zU5 snRNP (refs. 26 and 49; J.
Table 1. Mass spectrometric identification of U4yU6zU5 snRNP proteins
Protein name
Predicted
molecular mass
SGD ORF
name
No. of peptides
sequenced Putative homologyyfunctions
Prp8 280 kDa YHR165C 8 Unknown
Brr2 246 kDa YER172C 25 RNA helicase
Snu114 114 kDa YKL173W 19 GTPase
Prp6 104 kDa YBR055C 18 Zinc fingeryTPR
Snu66 66 kDa YOR308C 13 Unknown
Prp31 56 kDa YGR091W 8 Spliceosome assembly
Prp3 56 kDa YDR473C 11 Spliceosome assembly
Prp4 52 kDa YPR178W 8 WD repeats
Prp38 28 kDa YGR075C 4 snRNP stability
Snu23 23 kDa YDL098C 10 Zinc finger
SmB 22 kDa YER029C 4 Sm motifs
Uss1yLsm4 21 kDa YER112W 4 Sm motifs
Dib1 17 kDa YPR082C 6 Cell cycle
SmD1 16 kDa YGR074W 3 Sm motifs
Lsm8 15 kDa YJR022W 1 Sm motifs
SmD3 15 kDa YLR147C 4 Sm motifs
Lsm6 14 kDa YDR378C 1 Sm motifs
Snu13 13 kDa YEL026W 4 Nhp2 homology
SmD2 12 kDa YLR275W 6 Sm motifs
Lsm2 11 kDa YBL026W 3 Sm motifs
Lsm5 10.4 kDa YER146W 2 Sm motifs
SmE 10.4 kDa YOR159C 2 Sm motifs
SmF 9.6 kDa YPR182W 2 Sm motifs
SmG 8.5 kDa YFL017W-A 2 Sm motifs
SGD, Saccharomyces Genome Database (Stanford, CA); TPR, tetratrico-peptide repeat.
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Beggs personal communication). Further studies should show
whether these U6 Sm proteins are as stably bound to U6
snRNA as the canonical Sm proteins are to their snRNAs, as
well as the sequence to which the U6 Sm core binds.
Four Novel Proteins Are Associated with the Yeast U4yU6zU5
snRNP. We have identified four new proteins in the purified
U4yU6zU5 snRNP. The inessential Snu66 does not have any
known homologues or any sequence motifs that would allow us to
speculate as to what its function may be. There are, however, two
similarly sized, uncharacterized proteins in the isolated human
U4yU6zU5 snRNP to which it may correspond (38). As a
completely unknown protein, further biochemical and genetic
studies will help to gain insight into its function.
The essential Snu23 protein has a putative zinc finger domain,
a common nucleic acid binding motif. Although this does not help
to elucidate its function in the context of pre-mRNA splicing, it
demonstrates that it likely interacts with either a snRNA or the
pre-mRNA.
Dib1 is a 17-kDa yeast protein previously shown to be essential
in budding yeast (50). An incomplete human homologue exists in
the database, but its exact size remains unknown. Because there
exist two potential human U4yU6zU5 snRNP proteins of similar
size that are as yet uncharacterized, it is possible that the human
homologue is also associated with the U4yU6zU5 snRNP. The
isolation of Dib1 in the yeast U4yU6zU5 snRNP poses far more
questions that it answers. In fission yeast, its homologue dim1 was
isolated as a second-site mutation that reduced the restrictive
temperature of a cdc2 mutation. This implicated the fission yeast
gene product in the cell cycle, and, indeed, the depletion of this
protein leads to lethal arrest in G2. Many connections have been
found in fission yeast between pre-mRNA processing and the cell
cycle (55, 56). For instance, the fission yeast pre-mRNA process-
ing prp8 gene (coding for a putative RNA helicase) is allelic with
the cell cycle cdc28 gene (57). Overexpression of a portion of the
fission yeast prp4 gene leads to a cell cycle defect (58). In budding
yeast, the PRP20 gene first was characterized as a temperature-
sensitive mutant with a defect in pre-mRNA splicing (59). Fur-
ther analysis showed that this mutation has pleiotropic effects
ranging from improper mRNA 39 end formation and mRNA
transport defects to mitotic and chromosome condensation de-
fects in fission yeast and mammalian homologues. It functions
biochemically in nuclear trafficking as the Ran guanosine release
factor (60). Alleles of PRP8 and PRP22 in budding yeast also have
been shown to have cell cycle phenotypes (61, 62) but are clearly
involved in pre-mRNA splicing as well. It is difficult to separate
these effects to determine which are primary and which are
secondary. The demonstration that Dib1 is an integral U4yU6zU5
snRNP component is good evidence that, in this case, its primary
function may be in pre-mRNA splicing, with the cell cycle
phenotypes arising from secondary effects. A likely hypothesis is
that some genes coding for cell cycle components contain introns;
the inability to splice these pre-mRNAs during the critical junc-
ture in their expression in the cell cycle would make the produc-
tion of its gene product impossible, thereby arresting the cells at
that point in the cell cycle. Further biochemical and genetic
analysis will need to be done to demonstrate what the role of Dib1
is in pre-mRNA splicing.
The fourth novel protein identified in this study has been
termed Snu13. Although its function has not yet been deter-
mined, it is essential, and homologues from fission yeast,
worm, and man exist in the database (Fig. 4). Because of the
extensive identity of protein sequence, it is likely that these are
functional homologues, and, indeed, there exist similarly sized
proteins in the human U4yU6zU5 snRNP. Because there is
homology to the highly basic Nhp2 protein, which itself is a
snRNP component that has homology to two ribosomal sub-
units, it is possible that this is an RNA binding protein. Further
studies should shed light on what the function of this protein
is and with which proteins or RNAs it interacts.
Proteins Absent from the U4yU6zU5 snRNP. Two proteins
previously shown to be associated with the U4yU6zU5 snRNP
were not identified in this study. Prp18 is a 25-kDa protein
known to be associated with the U5 snRNP and incorporated
into the yeast U4yU6zU5 snRNP (63) and with the human
U4yU6zU5 snRNP (64). Spp381 is a 34-kDa protein that was
identified as a suppressor of prp38–1 and also has been shown
to be associated with the U4yU6zU5 snRNP. Prp18 antiserum
immunoprecipitated U4, U5, and U6 snRNAs at salt concen-
trations up to 200 mM, and hemagglutinin-tagged Spp381
immunoprecipitated U4, U5, and U6 snRNAs at salt concen-
trations up to 100 mM. By comparison, the U4yU6 and
FIG. 3. Mass spectrometry microsequencing spectrum from a Brr2
peptide. (A) Representative spectrum from an '1,158-Da tryptic
peptide derived from Brr2. (B) MSyMS mass spectrometry analysis of
fragmented 1,158-Da peptide. Masses calculated for the resulting ions
were correlated to the entire nonredundant protein database. The
labeled mass peaks for the Y99 ions represent the protein sequence
PDISSD from the Brr2 protein corresponding to amino acids 958–963.
FIG. 4. Snu13 is highly conserved from yeast to man. Sequences
with high degrees of identity to budding yeast Snu13(sc) were found
from Schizosaccharomyces pombe (Snu13sp), C. elegans (Snu13ce), and
human (Snu13hs). Regions of homology also were found with budding
yeast Nhp2. Sequences were aligned with the PILEUP program (GCG)
and were aligned in BOXSHADE (K. Hofman and M. Baron, Chemin des
Boveresses, Lausanne, Switzerland). Identical amino acids are shaded
black, with similar amino acids shaded gray.
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U4yU6zU5 snRNP component Prp4 is stably associated with
U4yU6zU5 snRNP at salt conditions at which the triple snRNP
dissociates and is stably associated with U4yU6 snRNP to even
higher salt concentrations (29). Even though Prp18 and
Spp381 are not present in preparations of U4yU6zU5 snRNP
isolated at 50 mM KCl, it is likely that the inability to identify
these two proteins is attributable to their relatively weaker
interactions with the U4yU6zU5 snRNP. It is also possible that
there exist other proteins that, because of their behavior in our
purification scheme, were not present in our preparation.
Further genetic and biochemical experimentation may eluci-
date other potential U4yU6zU5 snRNP proteins, as was shown
for the U1 snRNP (16).
In the purification of the U1 snRNP, it was shown that a
42-kDa protein copurified with the free U5 snRNP (15). This
protein also was not isolated in our studies, which indicated
that either the 42-kDa protein is not stably associated with the
U4yU6zU5 snRNP or, possibly, that it may leave the U5
snRNP on assembly of the U4yU6zU5 snRNP.
The human U4yU6zU5 snRNP also was shown to have
associated with it a 20-kDa cyclophyllin protein that was shown
to have proline isomerase activity (3, 53). Although there exist
sequence homologues in the yeast proteome, it was not isolated
in our purification. Immunoprecipitation studies using the
yeast homologues may prove whether it is indeed U4yU6zU5
snRNP-associated.
We have shown that the preparative purification and charac-
terization of snRNPs from yeast present in lower amounts than
U1 snRNP is feasible. Selection of the proper protein as an
affinity handle and the use of sensitive electrospray tandem mass
spectrometry of the isolated polypeptides has proven to be a
powerful technique for the characterization of large multicom-
ponent complexes from a variety of organisms. The mass spec-
trometry data presented here and data presented previously show
that there are at least 28 proteins associated with the yeast
U4yU6zU5 snRNP. Further experimentation on the proteins of
the yeast U4yU6zU5 snRNP should help to shed light on the
mechanism of pre-mRNA splicing, as well as to help identify the
interconnection between the cell cycle and mRNA processing.
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